On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Andrés Cervantes

ResearcherPublications, citations & collaboration network

Andrés Cervantes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Andrés Cervantes have?

ScholarIQindexed works

Andrés Cervantes has 1,118 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Andrés Cervantes have?

ScholarIQcitation count

Andrés Cervantes has 62,201 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Andrés Cervantes?

ScholarIQh-index

Andrés Cervantes has an h-index of 98 in OpenAlex.

What is the i10-index of Andrés Cervantes?

ScholarIQi10-index

Andrés Cervantes has an i10-index of 368 in OpenAlex.

What is the ORCID of Andrés Cervantes?

ScholarIQorcid

The ORCID for Andrés Cervantes is on the source record.

What is the OpenAlex record for Andrés Cervantes?

ScholarIQopenalex

The OpenAlex for Andrés Cervantes is on the source record.

What are the most-cited papers on Andrés Cervantes?

ScholarIQmost cited works
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédèric Selle, Mansoor R. Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh Parmar, Amit M. Oza
New England Journal of Medicine. 20112,162 CitationsOPEN ACCESS
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, Corrie A.M. Marijnen, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Annet G.H. Roodvoets, Irıs D. Nagtegaal, Regina G. H. Beets‐Tan, Lennart K. Blomqvist, Tone Fokstuen, Albert J. ten Tije, Jaume Capdevila, Mathijs P. Hendriks, Ibrahim Edhemović, Andrés Cervantes, Per J. Nilsson, Bengt Glimelius, Cornelis J.�H. van de Velde, Geke A.P. Hospers, Lars Østergaard, Frank Svendsen Jensen, Per Pfeiffer, K.E.J. Jensen, Mathijs P. Hendriks, Wilhelmina H. Schreurs, H.P. Knol, J.J. van der Vliet, Jurriaan B. Tuynman, A. Bruynzeel, Emile D. Kerver, Sebastiaan Festen, Monique E. van Leerdam, Geerard L. Beets, L. Dewit, C.J.A. Punt, Pieter J. Tanis, Elisabeth D. Geijsen, Peter Nieboer, Wim Bleeker, Albert J. ten Tije, Rogier M. P. H. Crolla, Addy C.M. van de Luijtgaarden, Jan Willem T. Dekker, J.M. Immink, Frank J. Jeurissen, Andreas Marinelli, Heleen M. Ceha, Tanja C. Stam, P. Quarles an Ufford, Willem H. Steup, Alex L.T. Imholz, R.J.I. Bosker, Jasper Bekker, G.J. Creemers, Grard A. P. Nieuwenhuijzen, Henk van den Berg, Wendy M. van der Deure, Roderick F. Schmitz, Johan M. van Rooijen, Annette F. T. Olieman, A.C.M. van den Bergh, Derk Jan A. de Groot, Klaas Havenga, Jannet C. Beukema, Jacob D. de Boer, Peter H.J.M. Veldman, Ester Siemerink, J.W.P. Vanstiphout, B. De Valk, Q. A. J. Eijsbouts, M. Polée, Christiaan Hoff, Annerie Slot, H.W. Kapiteijn, Koen Peeters, Femke P. Peters, P.A. Nijenhuis, Sandra A. Radema, Hans De Wilt, Pètra M. Braam, G.J. Veldhuis, Daniël A. Hess, Tom Rozema, O. Reerink, Daan ten Bokkel Huinink, A. Pronk, Josephine M. I. Vos, Metin Tascilar, Gijs A. Patijn, Christian Kersten, Odd Mjåland, Marianne G. Guren, Arild Nesbakken, Janez Benedik, Ibrahim Edhemović, Vaneja Velenik, Jaume Capdevila, Eloy Espín, Ramón Salazar
The Lancet Oncology. 20201,669 CitationsOPEN ACCESS
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung‐Won Park‐Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh Parmar, Timothy Perren
The Lancet Oncology. 2015868 CitationsOPEN ACCESS
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon Håvard Loge, Matti Aapro, Tit Albreht, Rebecca Anderson, Éduardo Bruera, Cinzia Brunelli, Augusto Caraceni, Andrés Cervantes, David C. Currow, Luc Deliëns, Marie Fallon, Xavier Gómez‐Batiste, Kjersti Støen Grotmol, Breffni Hannon, Dagny Faksvåg Haugen, Irene J Higginson, Marianne Jensen Hjermstad, David Hui, Karin Jordan, Geana Paula Kurita, Philip Larkin, Guido Miccinesi, Friedemann Nauck, Rade Pribakovic, Gary Rodin, Per Sjøgren, Patrick Stone, Camilla Zimmermann, Tonje Lundeby
The Lancet Oncology. 2018847 CitationsOPEN ACCESS
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, George Pentheroudakis, Kentaro Yamazaki, Rui‐Hua Xu, Tae‐Woo Kim, Muhammad Ismail, Iain Tan, Kun‐Huei Yeh, Axel Grothey, S. Zhang, Joong Bae Ahn, M.Y. Mastura, Dawn Q. Chong, Liqun Chen, Scott Kopetz, Takako Eguchi-Nakajima, Hiromichi Ebi, Atsushi Ohtsu, Andrés Cervantes, Kei Muro, Josep Tabernero, Hironobu Minami, Fortunato Ciardiello, Jean‐Yves Douillard
Annals of Oncology. 2017596 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial